Abstract
To investigate the underlying mechanisms of carcinogenesis, we have developed a technique to determine the frequency of genetic changes in prostatic carcinoma tissue. We have demonstrated that at a ratio of between 1:4 and 1:9 mutant-normal alleles, the signal from a mutant TP53 allele is not apparent after polymerase chain reaction (PCR) amplification and further direct sequencing or single-strand conformation polymorphism (SSCP) analysis. To bypass this problem, which is inherent in the heterogeneity of the prostate tissue and of the tumour, we selected areas of graded prostate tumours (Gleason score) from cryosectioned preparations, and microdissected these cells (20-100 cells). After anionic resin removal of proteins, PCR amplification of TP53 gene exons 5/6 and SSCP analysis, an abnormal SSCP band shift was observed in suspected tumour cells, compared with microdissected stromal cells used as an internal control, while (1) a crude preparation of tissue DNA carrying the tumour did not show any abnormality and (2) immunostaining by a set of monoclonal antibodies against TP53 protein remained negative. Nucleotide sequence analysis of the different bands confirmed the presence of a mutation in the TP53 gene exon 6 position 13 336 in an abnormal band for one specimen, while no mutation was detected in the normal SSCP band. By targeting recognised tumour cells we can find DNA mutations which are undetectable using the standard technique of whole-tissue DNA extraction, particularly in a heterogeneous tumour such as carcinoma of the prostate.
| Original language | English |
|---|---|
| Pages (from-to) | 946-951 |
| Number of pages | 6 |
| Journal | British journal of cancer |
| Volume | 72 |
| Issue number | 4 |
| Publication status | Published - Oct 1995 |
Keywords
- PROSTATE CANCER
- MICRODISSECTION
- MUTATION ANALYSIS
- P53
- POLYMERASE CHAIN-REACTION
- TUMOR SUPPRESSOR GENE
- MONOCLONAL-ANTIBODIES
- SIMIAN VIRUS-40
- P53 GENE
- CARCINOMA
- MUTATIONS
- TUMORIGENESIS
- ACCUMULATION
- ONCOGENESIS